查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529727

美国电子医疗市场规模、份额和趋势分析报告：按产品、最终用途和细分市场预测，2024-2030 年

U.S. eHealth Market Size, Share & Trends Analysis Report By Product (Telemedicine, Health Information Systems, mHealth, ePharmacy), By End Use (Providers, Payers, Patients), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国电子医疗市场的成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，美国电子医疗市场规模预计将达到3,766亿美元，2024年至2030年的复合年增长率为17.6%。

电子医疗保健市场的推动因素包括远端医疗和人工智慧等持续的技术进步、对医疗保健服务的需求不断增加、由于 COVID-19 大流行而加速采用、支持性法律规范以及以患者为中心的护理模式，这是由几个关键因素推动的。此外，电子处方笺由于能够简化药物管理并提高病患安全性，已成为电子医疗市场的显着驱动力。医疗保健提供者可以透过电子方式向药房发送准确、易于阅读的处方笺，从而减少错误并提高效率。

电子处方笺系统还透过为患者提供方便的处方药物和剂量说明来促进更好的用药依从性，最终改善医疗保健行业的健康结果并节省成本。例如，礼来公司 (Eli Lilly) 于 2024 年 1 月推出了 LillyDirect，这是一个数位平台，旨在简化针对糖尿病、肥胖和偏头痛等疾病的患者购买某些药物的流程。该平台将患者与独立的远距医疗提供者联繫起来，并提供疾病管理资源，提供直接获取药物的机会，并消除了从医生那里获取处方笺的传统步骤。此外，交换医疗资讯（HIE）透过促进互通性并确保医疗机构之间的无缝资料交换以改善护理协调，显着推动了电子医疗市场的发展。

HIE 透过提供全面的病患记录来提高护理的连续性，从而实现更快的诊断和更好的结果。 HIE 透过消除手动资料输入和重复检查来简化流程、减少重复并提高效率。 HIE 允许患者存取和共用其健康记录，从而赋予患者权力，并有助于更好地参与和决策。例如，2023 年 12 月，安大略省 21 家医院和医疗机构推出了由 Oracle Health 提供支援的安大略省 eHub 健康资讯交换 (HIE)。这个创新平台可以在参与的医疗机构之间无缝、安全地共用患者资料。透过利用安大略省 eHub，这些机构可以简化管理流程，最大限度地减少管理成本，并加强护理协调，以改善患者的医疗保健结果。

此外，政府倡议也对市场成长做出了重大贡献。例如，2023 年 5 月，美国卫生与公众服务部 (HHS) 宣布联邦在远端医疗和远端医疗处方方面具有灵活性，以确保患者持续获得基本护理。这些灵活性最初是在 COVID-19 公共卫生紧急情况 (PHE) 期间实施的，后来透过《2023 年综合拨款法》延长至 2024年终。主要条款包括在全国范围内扩大远距远端医疗服务的覆盖范围，允许患者家用中接受医疗保险覆盖的远端医疗就诊，以及无需前往医疗机构等。此外，对于无法使用智慧型手机或电脑等影像媒体的人来说，某些医疗保险远端医疗咨询现在可以使用电话等纯音讯技术进行。

美国电子医疗市场报告亮点：

  • 以产品来看，医疗资讯系统领域占比最大，2023年为42.0%。医疗保健支出的增加和IT基础设施的改善推动了市场的成长。远端患者监护日益增长的需求也促进了该领域的采用。
  • 受管理病患工作流程和资料的电子医疗解决方案带来的效率的推动，供应商最终用途细分市场在 2023 年占据最大份额，达到 53.1%。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国电子医疗市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 药用食品市场价格分析
  • 产业分析
    • 使用者观点分析
    • 主要最终用户
  • 技术展望
  • 法律规范
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业挑战与机会分析
  • 电子医疗市场分析工具
    • 波特的分析
    • PESTEL分析
  • 电子医疗产业重大交易及策略联盟分析
  • COVID-19 的影响
  • 案例研究见解

第四章美国电子医疗市场：依产品估算及趋势分析

  • 定义和范围
  • 2023 年及 2030 年按产品分類的市场占有率分析
  • 细分仪表板
  • 电子医疗市场：依产品分类，2018-2030
  • 远端医疗
  • 健康资讯系统
  • 行动医疗
  • 网路药局
  • 电子处方
  • 电脑化医令系统(CPOE)

第五章美国电子医疗市场：最终用途预测与趋势分析

  • 定义和范围
  • 2023 年和 2030 年按最终用途分類的市场占有率分析
  • 细分仪表板
  • 电子医疗市场：依最终用途分类，2018-2030 年
  • 提供者
  • 付款人
  • 病人

第六章 竞争状况

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 公司市场占有率分析
  • 企业热力图分析
  • 策略规划
    • 扩张
    • 併购
    • 伙伴关係与协作
    • 新产品发布
    • 研究与开发
  • 公司简介
    • CVS Health
    • Teladoc Health, Inc.
    • American Well
    • Veradigm LLC
    • UNITEDHEALTH GROUP
    • Medtronic
    • Epocrates
    • Telecare Corporation
    • Medisafe
    • Set Point Medical
    • IBM
    • Doximity, Inc.
    • LiftLabs
Product Code: GVR-4-68040-339-7

U.S. eHealth Market Growth & Trends:

The U.S. eHealth market size is expected to reach USD 376.6 billion by 2030, registering a CAGR of 17.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The eHealth market is driven by several key factors, including ongoing technological advancements like telemedicine and AI, increased demand for healthcare services, accelerated adoption due to the COVID-19 pandemic, supportive regulatory frameworks, a shift towards patient-centric care models, the cost-effectiveness of digital solutions, data analytics for patient health management, and improved global connectivity. Furthermore, e-prescription is a notable driver of the eHealth market due to its ability to streamline medication management and improve patient safety. It enables healthcare providers to electronically send accurate and legible prescriptions to pharmacies, reducing errors and enhancing efficiency.

E-prescription systems also facilitate better medication adherence by providing patients convenient access to their prescribed medications and dosage instructions, ultimately leading to improved health outcomes and cost savings in the healthcare industry. For instance, in January 2024, Eli Lilly introduced LillyDirect, a digital platform designed to streamline purchasing specific medications for patients with prescriptions addressing conditions like diabetes, obesity, and migraine. This platform offers direct access to medicines by linking patients with independent Telehealth providers and providing resources for disease management, eliminating the traditional steps of obtaining a prescription from a physician. In addition, Health Information Exchange (HIE) significantly boosts the eHealth market by promoting interoperability and ensuring seamless data exchange among healthcare entities for improved care coordination.

HIE enhances care continuity by providing comprehensive patient records, leading to faster diagnoses and better outcomes. It streamlines processes, reduces redundancies, and improves efficiency by eliminating manual data entry and repeated tests. HIE empowers patients by allowing them to access and share their health records, contributing to better engagement and decision-making. For instance, in December 2023, a group comprising 21 Ontario hospitals and healthcare facilities launched the Ontario eHub Health Information Exchange (HIE) powered by Oracle Health. This innovative platform enables seamless and secure sharing of patient data among participating healthcare organizations. By leveraging the Ontario eHub, these entities can streamline administrative processes, minimize overhead costs, and enhance care coordination to improve patient healthcare outcomes.

Moreover, the government's initiatives significantly contributed to market growth. For instance, in May 2023, the U.S. Department of Health and Human Services (HHS) announced federal flexibilities regarding telehealth and telemedicine prescriptions to ensure ongoing access to essential care for patients. Initially implemented during the COVID-19 Public Health Emergency (PHE), these flexibilities were extended through the end of 2024 via the Consolidated Appropriations Act of 2023. Key provisions include expanded access to telehealth services nationwide, allowing patients to receive Medicare-covered telehealth visits from their homes, and eliminating the need for travel to healthcare facilities. Furthermore, certain Medicare telehealth consultations can now be conducted using audio-only technology, like telephones, for individuals unable to utilize audio and video mediums, such as smartphones or computers.

U.S. eHealth Market Report Highlights:

  • Based on products, the healthcare information systems segment held the largest share of 42.0% in 2023. The market growth is attributed to increasing healthcare spending and improvements in IT infrastructure. In addition, the growing need for remote patient monitoring is increasing its adoption
  • The providers end use segment accounted for the largest share of 53.1% in 2023, driven by the efficiencies delivered by the eHealth solutions in managing patient workflows and data

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. End Use Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. eHealth Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Pricing Analysis Around the Medical Food Market
  • 3.3. Industry Analysis
    • 3.3.1. User Perspective Analysis
    • 3.3.2. Key End Users
  • 3.4. Technology Outlook
  • 3.5. Regulatory Framework
  • 3.6. Market Dynamics
    • 3.6.1. Market Drivers Analysis
      • 3.6.1.1. Increasing need to manage regulatory compliance
      • 3.6.1.2. Rising healthcare costs
      • 3.6.1.3. Increasing prevalence of chronic disease
      • 3.6.1.4. Rising adoption of digital healthcare
      • 3.6.1.5. Growing need for patient-centric healthcare delivery
    • 3.6.2. Market Restraints Analysis
    • 3.6.3. Industry Challenges and Opportunity Analysis
  • 3.7. eHealth Market Analysis Tools
    • 3.7.1. Porter's Analysis
      • 3.7.1.1. Bargaining power of the suppliers
      • 3.7.1.2. Bargaining power of the buyers
      • 3.7.1.3. Threats of substitution
      • 3.7.1.4. Threats from new entrants
      • 3.7.1.5. Competitive rivalry
    • 3.7.2. PESTEL Analysis
      • 3.7.2.1. Political landscape
      • 3.7.2.2. Economic and Social landscape
      • 3.7.2.3. Technological landscape
      • 3.7.2.4. Environmental landscape
      • 3.7.2.5. Legal landscape
  • 3.8. Major Deals & Strategic Alliances Analysis in the eHealth Industry
  • 3.9. Impact of COVID-19
  • 3.10. Case Study Insights

Chapter 4. U.S. eHealth Market: Product Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. eHealth Market: By Product, 2018 to 2030
  • 4.5. Telemedicine
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Health Information Systems
    • 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.1. Electronic Health Record

4.6.1.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

      • 4.6.1.2. Electronic Medical Record

4.6.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

      • 4.6.1.3. Patient Engagement Solution

4.6.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

      • 4.6.1.4. Population Health Management

4.6.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

  • 4.7. mHealth
    • 4.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.7.1.1. Monitoring services

4.7.1.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

      • 4.7.1.2. Diagnosis services

4.7.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

      • 4.7.1.3. Healthcare Systems Strengthening Services

4.7.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

      • 4.7.1.4. Others

4.7.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

  • 4.8. ePharmacy
    • 4.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.9. E-Prescribing
    • 4.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.10. Computerized Physician Order Entry
    • 4.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. U.S. eHealth Market: End Use Estimates& Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share Analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. eHealth Market: By End Use, 2018 to 2030
  • 5.5. Providers
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Payers
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Patients
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Market Share Analysis
  • 6.4. Company Heat Map Analysis
  • 6.5. Strategy Mapping
    • 6.5.1. Expansion
    • 6.5.2. Mergers & Acquisition
    • 6.5.3. Partnerships & Collaborations
    • 6.5.4. New Product Launches
    • 6.5.5. Research And Development
  • 6.6. Company Profiles
    • 6.6.1. CVS Health
      • 6.6.1.1. Participant's Overview
      • 6.6.1.2. Financial Performance
      • 6.6.1.3. Product Benchmarking
      • 6.6.1.4. Recent Developments
    • 6.6.2. Teladoc Health, Inc.
      • 6.6.2.1. Participant's Overview
      • 6.6.2.2. Financial Performance
      • 6.6.2.3. Product Benchmarking
      • 6.6.2.4. Recent Developments
    • 6.6.3. American Well
      • 6.6.3.1. Participant's Overview
      • 6.6.3.2. Financial Performance
      • 6.6.3.3. Product Benchmarking
      • 6.6.3.4. Recent Developments
    • 6.6.4. Veradigm LLC
      • 6.6.4.1. Participant's Overview
      • 6.6.4.2. Financial Performance
      • 6.6.4.3. Product Benchmarking
      • 6.6.4.4. Recent Developments
    • 6.6.5. UNITEDHEALTH GROUP
      • 6.6.5.1. Participant's Overview
      • 6.6.5.2. Financial Performance
      • 6.6.5.3. Product Benchmarking
      • 6.6.5.4. Recent Developments
    • 6.6.6. Medtronic
      • 6.6.6.1. Participant's Overview
      • 6.6.6.2. Financial Performance
      • 6.6.6.3. Product Benchmarking
      • 6.6.6.4. Recent Developments
    • 6.6.7. Epocrates
      • 6.6.7.1. Participant's Overview
      • 6.6.7.2. Financial Performance
      • 6.6.7.3. Product Benchmarking
      • 6.6.7.4. Recent Developments
    • 6.6.8. Telecare Corporation
      • 6.6.8.1. Participant's Overview
      • 6.6.8.2. Financial Performance
      • 6.6.8.3. Product Benchmarking
      • 6.6.8.4. Recent Developments
    • 6.6.9. Medisafe
      • 6.6.9.1. Participant's Overview
      • 6.6.9.2. Financial Performance
      • 6.6.9.3. Product Benchmarking
      • 6.6.9.4. Recent Developments
    • 6.6.10. Set Point Medical
      • 6.6.10.1. Participant's Overview
      • 6.6.10.2. Financial Performance
      • 6.6.10.3. Product Benchmarking
      • 6.6.10.4. Recent Developments
    • 6.6.11. IBM
      • 6.6.11.1. Participant's Overview
      • 6.6.11.2. Financial Performance
      • 6.6.11.3. Product Benchmarking
      • 6.6.11.4. Recent Developments
    • 6.6.12. Doximity, Inc.
      • 6.6.12.1. Participant's Overview
      • 6.6.12.2. Financial Performance
      • 6.6.12.3. Product Benchmarking
      • 6.6.12.4. Recent Developments
    • 6.6.13. LiftLabs
      • 6.6.13.1. Participant's Overview
      • 6.6.13.2. Financial Performance
      • 6.6.13.3. Product Benchmarking
      • 6.6.13.4. Recent Developments

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 U.S. ehealth market, by Product, 2018 - 2030 (USD Million)
  • Table 4 U.S. ehealth market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 eHealth Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (Part 1)
  • Fig. 9 Segment Snapshot (Part 2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 eHealth- Market Size and Growth Prospects (USD Billion)
  • Fig. 12 eHealth Market : Industry Value Chain Analysis
  • Fig. 13 eHealth Market : Market Dynamics
  • Fig. 14 eHealth Market : PORTER's Analysis
  • Fig. 15 eHealth Market : PESTEL Analysis
  • Fig. 16 eHealth Market Share by product 2023 & 2030 (USD Billion)
  • Fig. 17 eHealth Market ,by product: Market Share, 2023 & 2030
  • Fig. 18 Telemedicine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 19 Health Information Systems Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 20 Electronic Health Record Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 21 Electronic Medical Record Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 22 Patient Engagement Solution Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 23 Population Health Management Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 24 mHealth Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 25 Monitoring services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 26 Diagnosis services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 27 Healthcare Systems Strengthening Services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 28 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 29 ePharmacy Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 30 E-Prescribing Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 31 Computerized Physician Order Entry Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 eHealth Market, by End Use: Key Takeaways
  • Fig. 33 eHealth Market, by End Use: Market Share, 2023 & 2030
  • Fig. 34 Providers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 35 Payers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 36 Patients Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 37 Key Company Categorization
  • Fig. 38 Company Market Positioning
  • Fig. 39 Key Company Market Share Analysis, 2023
  • Fig. 40 Strategic Framework